Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 8,581-8,592 of 10,592
Drug study icon
CompletedNCT01291511

Relapse Prevention Study in people with Schizophrenia

This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, India, Ukraine
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02030288

Relational Agent for Alcohol Screening and Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Addiction
Drug study icon
WithdrawnNCT05890768

Relationship Between Efficacy of Lumateperone and Brain Glutamate and Dopamine

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of New Mexico
Condition
Schizophrenia
Other study type icon
CompletedNCT01652443

Relationships and Health in the OEF/OIF Veteran Population

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SuicidalityOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
VA Eastern Colorado Health Care System
Condition
Suicidality
Drug study icon
CompletedNCT04922593

Relative Bioavailability of LY03010 Compared to Listed Drug

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01245348

Relative Effectiveness of Schizophrenia Therapy Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Schizophrenia, BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Medco Health Solutions, Inc.
Condition
Schizophrenia, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.